MS

Morgan Stanley
D

MS

Arincen79/100B
181.420
USD
-1.04
(-0.57%)
Post Trading·181.950USD+0.530(+0.29%)
Last updated: · Delayed 15 min
Fair value193.70Plus-6%116Price 181.42269
Q4 FY2026 · Earnings report
EPS estimate 2.93Revenue estimate 20.26B
OverviewFinancialsNewsForecastEarningsDividendsCompany

Morgan Stanley net income 1985–2026

Morgan Stanley earned 4.91B USD in Q3 FY2026, the three months to 30 September 2026, up 6.5% on the same quarter a year before. Morgan Stanley's net income over the last twelve months was 20.53B USD, up 26.9% on the twelve months before. In fiscal year 2025 it earned 16.86B USD, up 25.9% on the year before.

Last updated 8 Nov 2026 · Next report 14 Jan 2027

Net income

Net income · +10.7% a year over 10 yearsNet margin

Growth

Fiscal yearPeriod endingNet incomeGrowthNet marginRevenue
TTM30 Sept 202620.53B+26.87%25.97%79.03B
FY202531 Dec 202516.86B+25.92%25.56%65.97B
FY202431 Dec 202413.39B+47.35%23.24%57.62B
FY202331 Dec 20239.09B-17.61%17.93%50.67B
FY202231 Dec 202211.03B-26.64%21.97%50.21B
FY202131 Dec 202115.03B+36.72%26.65%56.41B
FY202031 Dec 202011.00B+21.61%23.99%45.83B
FY201931 Dec 20199.04B+3.36%23.16%39.05B
FY201831 Dec 20188.75B+43.15%23.20%37.71B
FY201731 Dec 20176.11B+2.21%17.05%35.85B
FY201631 Dec 20165.98B-2.42%18.28%32.71B
FY201531 Dec 20156.13B+76.72%18.42%33.26B
FY201431 Dec 20143.47B+18.25%10.68%32.47B
FY201331 Dec 20132.93B+4,342.42%9.53%30.78B
FY201231 Dec 201266.00M-98.38%0.27%24.64B
FY201131 Dec 20114.09B-13.14%13.35%30.59B
FY201031 Dec 20104.70B+249.41%16.02%29.36B
FY200931 Dec 20091.35B-21.15%6.23%21.60B
FY200831 Dec 20081.71B-46.81%9.66%17.66B
FY200730 Nov 20073.21B-57.05%12.84%24.99B
FY200630 Nov 20067.47B+51.29%26.22%28.49B
FY200530 Nov 20054.94B+10.10%21.75%22.71B
FY200430 Nov 20044.49B+18.46%18.93%23.70B
FY200330 Nov 20033.79B+26.74%17.12%22.12B
FY200230 Nov 20022.99B-15.14%14.61%20.45B
FY200130 Nov 20013.52B-35.47%15.25%23.10B
FY200030 Nov 20005.46B+13.88%20.26%26.93B
FY199930 Nov 19994.79B+46.25%21.71%22.07B
FY199830 Nov 19983.28B+26.68%18.60%17.62B
FY199730 Nov 19972.59B+171.81%15.84%16.33B
FY199631 Dec 1996951.40M+11.09%12.75%7.46B
FY199531 Dec 1995856.40M+15.59%13.34%6.42B
FY199431 Dec 1994740.90M+22.75%13.34%5.55B
FY199331 Dec 1993603.60M+18.24%12.06%5.01B
FY199231 Jan 1993510.50M+7.45%34.33%1.49B
FY199131 Dec 1991475.10M+75.70%37.54%1.27B
FY199031 Dec 1990270.40M-38.96%25.22%1.07B
FY198931 Dec 1989443.00M+12.27%33.45%1.32B
FY198831 Dec 1988394.60M+70.90%—0.00
FY198731 Dec 1987230.90M+14.70%—0.00
FY198631 Dec 1986201.30M+90.08%—0.00
FY198531 Dec 1985105.90M——0.00

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Morgan Stanley's profit

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.